MoneyWorks4Me

Aurobindo Pharma informs about earnings call

28 Oct 2025 Evaluate
Pursuant to Regulation 30(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Aurobindo Pharma has informed that it enclosed the schedule of Earnings Call to be held on November 6, 2025 at 8:30 am (IST) on Unaudited Financial Results of the Company for the second quarter and half year ended September 30, 2025.

The above information is a part of company’s filings submitted to BSE.  
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..